U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C21H25NO4.ClH
Molecular Weight 391.888
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of TETRAHYDROPALMATINE HYDROCHLORIDE, (+)-

SMILES

Cl.COC1=CC=C2C[C@H]3N(CCC4=CC(OC)=C(OC)C=C34)CC2=C1OC

InChI

InChIKey=MGSZZQQRTPWMEI-UNTBIKODSA-N
InChI=1S/C21H25NO4.ClH/c1-23-18-6-5-13-9-17-15-11-20(25-3)19(24-2)10-14(15)7-8-22(17)12-16(13)21(18)26-4;/h5-6,10-11,17H,7-9,12H2,1-4H3;1H/t17-;/m1./s1

HIDE SMILES / InChI
TETRAHYDROPALMATINE, (+)- is an alkaloid found in the plants of the Carydalis species. Tetrahydropalmatine (THP) has two enantiomers with different effects on the brain dopaminergic system. Dopamine (DA) content reduction in the rat striatum induced by d-THP is much more dose-dependent. At a small dose, d-THP predominantly reduced the DA level but left serotonin and noradrenaline level unaffected. d-THP is probably a DA depletor. There were stereoselective differences between the two THP enantiomers on the activity of cytochrome P450 (CYP450) isozymes, i.e., d-THP had the potential to inhibit the activities of CYP2D6 and CYP1A2 isozymes, while l-THP inhibited CYP1A2 isozyme and induced CYP3A4 and CYP2C9 isozymes. The plasma levels of l-THP were always higher than those of d-THP in rats.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
13.9 µM [IC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
PubMed

PubMed

TitleDatePubMed
Evaluation of Tetrahydropalmatine Enantiomers on the Activity of Five Cytochrome P450 Isozymes in Rats Using a Liquid Chromatography / Mass Spectrometric Method and a Cocktail Approach.
2015-08
[Stereoselective pharmacokinetics of tetrahydropalmatine in rats].
2005-08
[Brain dopamine depleted by d-tetrahydropalmatine].
1987-05
Different effects of enantiomers of tetrahydropalmatine on dopaminergic system.
1986-10
[Coreximine and related compounds. V. Total synthesis of (+-)-- tetrahydropalmatine and abnormal reaction of halogen substitution. (Studies on the syntheses of heterocyclic compounds. CXCIV)].
1967-09
Patents

Patents

Sample Use Guides

Mice: 10 mg/kg
Route of Administration: Intraperitoneal
In Vitro Use Guide
d-THP hadn't an affinity to the rat dopamine receptor even at concentrations higher than 100 or 1000 uM.
Name Type Language
NSC-132058
Preferred Name English
TETRAHYDROPALMATINE HYDROCHLORIDE, (+)-
Common Name English
6H-DIBENZO(A,G)QUINOLIZINE, 5,8,13,13A-TETRAHYDRO-2,3,9,10-TETRAMETHOXY-, HYDROCHLORIDE (1:1), (13AR)-
Systematic Name English
TETRAHYDROPALMATINE D-FORM HYDROCHLORIDE [MI]
Common Name English
Code System Code Type Description
FDA UNII
3W2KMH3XL9
Created by admin on Mon Mar 31 21:59:57 GMT 2025 , Edited by admin on Mon Mar 31 21:59:57 GMT 2025
PRIMARY
PUBCHEM
23615997
Created by admin on Mon Mar 31 21:59:57 GMT 2025 , Edited by admin on Mon Mar 31 21:59:57 GMT 2025
PRIMARY
NSC
132058
Created by admin on Mon Mar 31 21:59:57 GMT 2025 , Edited by admin on Mon Mar 31 21:59:57 GMT 2025
PRIMARY
CAS
6024-83-5
Created by admin on Mon Mar 31 21:59:57 GMT 2025 , Edited by admin on Mon Mar 31 21:59:57 GMT 2025
PRIMARY